A Bioequivalence Study With a Combination Tablet Formulation of Rosiglitazone and Metformin (4mg/500mg) Compared to Concomitant Dosing of Rosiglitazone 4mg and Metformin 500mg Commercial Tablets-and a Dose Proportionality Study Comparing the 4mg/500mg and 1mg/500mg Combination Formulations.

Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.